Learn why clinical trials are crucial for medical advancements and how to navigate participation. Find out more about IBD ...

Jane Searfoss was inspired to become a child life specialist at Boston Children's Hospital because of her own experience ...

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and ...

Researchers have described the neurodegeneration that occurs in the nervous system of the bowel in Batten disease, a rare and fatal genetic condition. In their latest study, a team showed that gene ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

Mirikizumab is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to the p19 subunit of human interleukin (IL)-23.

"Our study suggests that vedolizumab is a viable option for induction and long-term maintenance therapy in children with IBD, ...

The multicentre, prospective, cohort study by Ohad Atia and colleagues1 on the long-term efficacy and safety of maintenance vedolizumab in paediatric patients with inflammatory bowel disease (IBD) ...

aDepartment Medicine, Division of Gastroenterology, Schulich School of Medicine, Western University, London, ON N6A 5B6, Canada bDepartment of Epidemiology and Biostatistics, Western University, ...

Children diagnosed with inflammatory bowel disease (IBD) face a significantly higher risk for venous thromboembolism (VTE) ...

Vaccines protect babies and children from potentially life-threatening diseases. Widespread childhood vaccination has reduced or eliminated deadly diseases like polio and smallpox. Vaccines currently ...